Application of definitions for conversion to secondary progressive MS in a Danish nationwide population
Tine Iskov Kopp(Frederiksberg Hospital), Melinda Magyari(University of Copenhagen), Zsolt Illés(Universität Hamburg), Peter Vestergaard Rasmussen(Aarhus University Hospital), Stephan Bramow(Copenhagen University Hospital), Finn Sellebjerg(Kaiser Permanente), Claudia Christina Hilt Kristensen(Aalborg University Hospital), Matthias Kant(Sygehus Sønderjylland)
Cited by 8
Related Papers
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
EFNS guidelines on diagnosis and management of neuromyelitis optica
|European Journal of Neurology|2010|469
Worldwide Incidence and Prevalence of Neuromyelitis Optica
|Neurology|2020|303
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
|Journal of Neurology Neurosurgery & Psychiatry|2016|297
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
|CNS Drugs|2014|293